Communicable and Infectious Diseases

District 202 recognizes that a student with a communicable and chronic infectious disease is eligible for all rights, privileges and services provided by law and Plainfield School District 202’s policies. The District shall balance those student rights with its obligation to protect the health of all District students and staff. 

To promote optimum health in the schools the District will follow the Illinois Department of Public Health (IDPH) Communicable Disease School Nurse Guidance.  Click here for more information If IDPH changes guidelines, the District will follow the most up-to-date guidelines. 

(“Exclude” means that the school will not permit attendance.)

COVID-19 Health and Safety Information

The CDC has streamlined its guidance for COVID-19 isolation, aligning it with protocols for other respiratory viruses such as RSV and the flu. For detailed information, please refer to the CDC Respiratory Virus Guidance.   

As a result, District 202 will treat COVID-19 the same as any respiratory illness moving forward. 

The updated guidance for all respiratory illnesses is as follows: 

  • Students and staff who are sick should stay home, however, there is not a required number of days to stay home.  

  • Individuals can return to school and normal activities when symptoms have been getting better overall for 24 hours, and if a fever was present, the fever has been gone for 24 hours without the use of a fever-reducing medication.

  • After resuming normal activities, individuals are recommended to take precautions for the next 5 days, including enhanced hygiene practices, wearing a well-fitting mask, maintaining distance from others, and COVID  testing to prevent further spread.

Individuals who have no symptoms but tested positive for a common seasonal respiratory virus are recommended to take precautions such as masking, enhanced hygiene practices, and social distancing for the next 5 days after the positive test.

For any additional questions, please refer to the CDC Respiratory Virus Guidance Update FAQs